Citação norma APA

Herting, F., Friess, T., Bader, S., Muth, G., Hölzlwimmer, G., Rieder, N., . . . Klein, C. (2014). Enhanced anti-tumor activity of the glycoengineered type II CD20 antibody obinutuzumab (GA101) in combination with chemotherapy in xenograft models of human lymphoma. Informa Healthcare.

Citação norma Chicago

Herting, Frank, Thomas Friess, Sabine Bader, Gunter Muth, Gabriele Hölzlwimmer, Natascha Rieder, Pablo Umana, and Christian Klein. Enhanced Anti-tumor Activity of the Glycoengineered Type II CD20 Antibody Obinutuzumab (GA101) in Combination With Chemotherapy in Xenograft Models of Human Lymphoma. Informa Healthcare, 2014.

Citação norma MLA

Herting, Frank, et al. Enhanced Anti-tumor Activity of the Glycoengineered Type II CD20 Antibody Obinutuzumab (GA101) in Combination With Chemotherapy in Xenograft Models of Human Lymphoma. Informa Healthcare, 2014.

Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.